Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07456592Recruiting

Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project)

Role: collaborator

NCT07238504Not ApplicableNot Yet Recruiting

Acupuncture for Post-hemorrhoidectomy Pain Control

Role: collaborator

NCT02488252Phase 2Unknown

Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy

Role: collaborator

NCT03535935Phase 2Unknown

Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

Role: collaborator

All 4 trials loaded